DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 886 filers reported holding DANAHER CORPORATION in Q3 2014. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,332,216 | +1.9% | 45,676 | -1.5% | 0.63% | +2.9% |
Q2 2023 | $11,125,440 | -6.2% | 46,356 | -1.5% | 0.61% | -10.0% |
Q1 2023 | $11,855,962 | -5.6% | 47,040 | -0.6% | 0.68% | -13.8% |
Q4 2022 | $12,560,205 | +1.6% | 47,322 | -1.1% | 0.79% | -1.2% |
Q3 2022 | $12,360,000 | +1.9% | 47,855 | 0.0% | 0.80% | +8.3% |
Q2 2022 | $12,132,000 | -15.6% | 47,855 | -2.4% | 0.74% | +8.2% |
Q1 2022 | $14,381,000 | -11.0% | 49,027 | -0.1% | 0.68% | -0.1% |
Q4 2021 | $16,153,000 | +7.0% | 49,097 | -1.0% | 0.68% | -7.9% |
Q3 2021 | $15,099,000 | +13.6% | 49,597 | +0.1% | 0.74% | +11.2% |
Q2 2021 | $13,291,000 | +19.2% | 49,527 | 0.0% | 0.67% | +7.6% |
Q1 2021 | $11,148,000 | +1.3% | 49,527 | 0.0% | 0.62% | -3.6% |
Q4 2020 | $11,002,000 | +4.9% | 49,527 | +1.6% | 0.64% | -9.2% |
Q3 2020 | $10,492,000 | +21.9% | 48,727 | +0.1% | 0.71% | +13.4% |
Q2 2020 | $8,608,000 | +27.2% | 48,677 | -0.4% | 0.62% | +16.2% |
Q1 2020 | $6,766,000 | -7.3% | 48,884 | +2.7% | 0.54% | +10.9% |
Q4 2019 | $7,302,000 | +6.3% | 47,579 | 0.0% | 0.48% | +0.8% |
Q3 2019 | $6,872,000 | +1.1% | 47,579 | 0.0% | 0.48% | +5.7% |
Q2 2019 | $6,800,000 | +8.3% | 47,579 | 0.0% | 0.46% | -0.9% |
Q1 2019 | $6,281,000 | +28.0% | 47,579 | 0.0% | 0.46% | +12.8% |
Q4 2018 | $4,906,000 | -5.1% | 47,579 | -0.0% | 0.41% | +12.7% |
Q3 2018 | $5,170,000 | +10.1% | 47,580 | 0.0% | 0.36% | +0.8% |
Q2 2018 | $4,695,000 | +1.5% | 47,580 | +0.7% | 0.36% | -4.3% |
Q1 2018 | $4,627,000 | +5.5% | 47,258 | 0.0% | 0.37% | +3.6% |
Q4 2017 | $4,386,000 | +8.2% | 47,258 | 0.0% | 0.36% | -0.6% |
Q3 2017 | $4,054,000 | +1.7% | 47,258 | 0.0% | 0.36% | 0.0% |
Q2 2017 | $3,988,000 | -1.4% | 47,258 | -0.0% | 0.36% | -5.7% |
Q1 2017 | $4,044,000 | +10.6% | 47,280 | +0.6% | 0.38% | +1.9% |
Q4 2016 | $3,657,000 | -0.7% | 46,975 | 0.0% | 0.38% | +14.9% |
Q3 2016 | $3,682,000 | -23.4% | 46,975 | -1.3% | 0.33% | -25.7% |
Q2 2016 | $4,805,000 | +2.2% | 47,575 | -4.0% | 0.44% | +4.2% |
Q1 2016 | $4,703,000 | +2.0% | 49,575 | -0.2% | 0.42% | +73.5% |
Q4 2015 | $4,613,000 | +9.1% | 49,662 | +0.1% | 0.24% | +10.9% |
Q3 2015 | $4,228,000 | -0.4% | 49,623 | +0.0% | 0.22% | +5.2% |
Q2 2015 | $4,246,000 | +0.8% | 49,605 | 0.0% | 0.21% | +4.5% |
Q1 2015 | $4,211,000 | +0.6% | 49,605 | +1.6% | 0.20% | +2.0% |
Q4 2014 | $4,185,000 | +12.8% | 48,826 | 0.0% | 0.20% | -5.7% |
Q3 2014 | $3,710,000 | -3.5% | 48,826 | 0.0% | 0.21% | -0.5% |
Q2 2014 | $3,844,000 | +3.9% | 48,826 | -1.0% | 0.21% | +4.0% |
Q1 2014 | $3,699,000 | -2.8% | 49,315 | 0.0% | 0.20% | -5.2% |
Q4 2013 | $3,807,000 | +11.3% | 49,315 | 0.0% | 0.21% | +7.0% |
Q3 2013 | $3,419,000 | +188.0% | 49,315 | +162.9% | 0.20% | +180.3% |
Q2 2013 | $1,187,000 | – | 18,757 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |